ClinicalTrials.Veeva

Menu

Prevention of Acute Mountain Sickness by Intermittent Hypoxia

H

Heidelberg University

Status

Completed

Conditions

Acute Mountain Sickness

Treatments

Other: Hypoxic Exposure

Study type

Interventional

Funder types

Other

Identifiers

NCT00559832
039/2006

Details and patient eligibility

About

Acclimatization by mountaineering prior to high altitude sojourns have shown to be effective in prevention of acute mountain sickness (AMS).

The aim of this study is to investigate whether intermittent exposure to normobaric hypoxia during sleep is also effective to prevent AMS.

Enrollment

75 patients

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy

Exclusion criteria

  • Altitude exposure above 2000 m 8 weeks prior or during the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

75 participants in 2 patient groups

Normoxia
No Intervention group
Description:
Sleeping in normoxia for 14 nights prior to one night at 4500 m
Hypoxia
Experimental group
Description:
Sleeping in normobaric hypoxia for 14 nights at altitudes from 2500 - 3300 m prior to one night at 4500 m
Treatment:
Other: Hypoxic Exposure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems